Significant Presence of Women in Oncology, but Still Under-Representation in Leadership Positions, Greek Survey Shows
New initiative aims to promote exchange of ideas among female oncologists and support women with cancer in Greece
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
New initiative aims to promote exchange of ideas among female oncologists and support women with cancer in Greece
For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression-free survival
Long-term follow-up from CLEOPATRA study presented at ESMO 2014 demonstrates ‘unprecedented’ benefit
Patients whose lung cancer has developed resistance to the drug gefitinib experience no statistically significant improvement in progression-free survival from continued treatment with the drug in addition to chemotherapy.
Phase III trials presented at the ESMO 2014 Congress report major advances in supportive care for cancer patients.
Study using thymidylate synthase as a predictive and prospective biomarker. Report on a trial with a drug that targets the folate receptor.
The first direct comparison of treating non-squamous lung cancer with either pemetrexed or docetaxel in addition to cisplatin has shown that the two combinations achieve similar progression-free survival, although docetaxel was associated with more frequent adverse events.
One of the most exciting features of immune checkpoint inhibitors (ICIs) is that they provide impressive tumour responses in metastatic cancers of different histologies
Phase III trial indicates the drug is safe and well tolerated in advanced non-small cell lung cancer
Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy
Presentations at ESMO 2014 examine the impact of in-utero exposure to chemotherapy and radiotherapy; the safety of lymph node biopsy in pregnancy; and the outcomes of unplanned pregnancy during cancer treatment
Fecal occult blood screening increases high-risk polyp detection by 89%. For high-risk patients, FOBT screening may be more efficient than colonoscopy.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.